Anti-fibrotic and anti-inflammatory activity of the dual CCR2 and CCR5 antagonist cenicriviroc in a mouse model of NASH - Lefebvre, E; Hashiguchi, T; Jenkins, H (Hepatology, 2013)
, et al.